Saturday, March 13, 2010 5:01:53 PM
I also wouldn't be surprised to see the PR come on Thursday or Friday given this is a re-submission.
Assuming it gets approved, I'm thinking $6-10 is probably a reasonable target out of the shoot. If a partnering deal follows immediately I think we could see $15-20 in short order. If not, price will probably pull back to the $5-6 range.
I think I read where the worldwide insomnia drug market is somewhere around $6.4B and the U.S. is 75% of the market. If Silenor could get 10% of the market with the right partner, a reasonable market cap would be around $500M (which is where I get the $20 target).
All MHO but I'm in for the ride, as I think this gets approved, and the biggest move doesn't come until the partnering deal is announced.
GLTA,
Murocman
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM